Market Analysis
The global antipsychotic drugs market is touted to touch USD 18.5 billion at a staggering 5.7% CAGR over the predicted years (2021-2027). Psychosis is a disorder where the person may face serious distortion of behavior, thought, perception and recognition of reality. The patients may experience hallucinations and delusions along with having wrong evaluation and misperception of other people, facts or situations. In itself psychosis is not a condition but rather gets triggered due to other conditions such as stress, traumatic experiences or physical conditions namely brain tumor, Parkinson’s disease or due to alcohol or drug misuse. Due of lack of insight, the person is unaware that he/she is acting and thinking strangely. Antipsychotic drugs also known as neuroleptics or major tranquilizers are used primarily for treating psychosis. Such drugs help in blocking the dopamine receptors in the brain’s dopaminergic pathways, thus repressing the dopamine’s effect that is linked directly to psychotic experiences. These drugs are used to treat common psychotic disorders including bipolar disorder, delusions, hallucinations, schizophrenia and others.
Get Request Free Sample @ https://www.marketresearchfuture.com/sample_request/2784
There are many factors that is driving the growth of the antipsychotic drugs market. Some of these factors as per the Market Research Future (MRFR) report include increasing number of people suffering from schizophrenia, increasing prevalence of psychotic disorders, over prescription of antipsychotic drugs, increased drug abuse, antipsychotic drug addiction, and huge funds being invested on R&D activities, and introduction of novel antipsychotic compounds. On the contrary, factors such as poor efficacy and efficiency of anti-psychotic drugs, various side effects associated to taking the drugs such as high addiction rate, vomiting, drowsiness and insomnia, social stigma, poor drug development pipeline and stringent regulatory framework are likely to act as deterrents in the growth of antipsychotic drugs market over the predicted years.
Regional Overview
The antipsychotic drugs market report covers companies functional in the antipsychotic drugs market spread across regional markets of North America, Europe, Asia-Pacific (APAC), and the rest of the world. The regional analysis of the antipsychotic drugs market can be found in the market research report. The North American antipsychotic drugs market has several key players functioning in the United States, Canada, and Mexico. Europe has companies in the antipsychotic drugs market across Germany, France, Spain, Italy, and the United Kingdom. The antipsychotic drugs market of the Middle East, Africa, and other regions has also been studied by analysts. A detailed analysis of the antipsychotic drugs market across India, China, and Japan in the Asia-Pacific region is also available for further study.
Competitive Landscape
The antipsychotic drugs market is corroborated by a large number of people suffering from mental stress. The population growth as well as increasing demand of antipsychotic drugs market based solutions also accelerate the market growth. However, the antipsychotic drugs market can be affected due to negative impact on health as well as concerns regarding health problems such as weight gain and diabetes. The antipsychotic drugs market research report covers all such factors assisting companies in the antipsychotic drugs market to improve their plans and portfolio. The antipsychotic drugs market research report also provides company profiles of major businesses. The antipsychotic drugs market report highlights crucial details about organizations operating across North America, Europe, Asia-Pacific (APAC), and the rest of the world regional markets. The details available in the antipsychotic drugs market report cover company strategies, revenue, company size, and mergers and acquisitions in the antipsychotic drugs market. New entrants as well as established organizations can use the data from antipsychotic drugs market report to further plan their strategies.
Industry News
Lumateperone is FDA-approved for the treatment of schizophrenia as a mechanistically novel agent. 2 short-term placebo-controlled trials in patients with schizophrenia have shown effectiveness and beneficial tolerability of Lumateperone. This open-label research tested the short-term efficacy and resistance of lumateperone, which was modified from prior antipsychosis of external patients who had healthy schizophhrenia.
Key Players
Leading players profiled in the antipsychotic drugs market include Johnson & Johnson, GlaxoSmithKline plc, AstraZeneca, Pfizer Inc., Bristol-Myers Squibb, Eli Lilly & Co. and others.
March 2019- Dementia Training Australia of late has come up with a new tool that will assist all residential aged care providers in monitoring and reducing the utilization of antipsychotic medicines in facilities. The main objective of launching this tool is for improving practices on the use of medication particularly in aged care. All aged care health experts having experience in the antipsychotic medicines can have access to this tool that will enable providers in monitoring changes in their utilization of antipsychotic medicines for residents. The providers can assess the latest Aged Care Quality Standards soon, from 1st July, 2019.
Table of Contents
1. REPORT PROLOGUE
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Primary Research
3.3. Secondary Research
3.4. Market Size Estimation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Porter’s Five Forces Analysis
5.1.1. Bargaining Power of Suppliers
5.1.2. Bargaining Power of Buyers
5.1.3. Threat of New Entrants
5.1.4. Threat of Substitutes
5.1.5. Intensity of Rivalry
5.2. Value Chain Analysis
Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/antipsychotic-drugs-market-2784
Related reports link:-
Healthcare IT Market
Blood Testing Market
Picture Archiving and Communication Systems Market
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
